The Bloc just keeps on growing, with revenue rising to $53.4 million in 2020 and momentum continuing so far in 2021. And while it’s added plenty of new business, including Boehringer Ingelheim and Eli Lilly (Jardiance), 70% of revenue growth stems from existing clients. Those include Otsuka/Lundbeck (Abilify Maintena), Amarin (Vazkepa global), Regeneron (REGN-COV) and BD (global diabetes care.)
The agency also opened new offices and expanded offers that drive value and efficiency for clients. And as part of an international network of like-minded, independent agencies across the globe, it extended its reach in 2020 to include agencies in Austria, the Netherlands, Belgium, Portugal and Greece. The network is now present in 34 markets with over 1,300 employees.
Its Value Builders market access team experienced unprecedented growth, including a launch assignment for Jazz and subsequently introducing three oncology brands.
It added The Bloc Science Foundry, a new medical communications practice. And with people consuming video content now more than ever, it debuted The Bloc Storytellers to raise the bar in healthcare video content.
“The Bloc team has been a true partner, providing strategic expertise and executional excellence, frequently in high-pressure launch situations where time was of the essence,” says Michael Ross, senior director, HCP marketing for Amarin’s Vascepa. “Within each of these daunting situations, the team has demonstrated a can-do attitude, delivering in a timely and expert manner while proactively providing thoughtful ideas and suggestions. They have been a welcome extension of the brand team.”
